Evaluation of the carcinogenicity of inorganic arsenic
- PMID: 24040994
- DOI: 10.3109/10408444.2013.827152
Evaluation of the carcinogenicity of inorganic arsenic
Abstract
Inorganic arsenic (iAs) at high exposures is a human carcinogen, affecting mainly the urinary bladder, lung and skin. We present an assessment of the mode of action (MOA) of iAs's carcinogenicity based on the United States Environmental Protection Agency/International Programme on Chemical Safety (USEPA/IPCS) framework, focusing primarily on bladder cancer. Evidence is presented for a MOA involving formation of reactive trivalent metabolites interacting with critical cellular sulfhydryl groups, leading to cytotoxicity and regenerative cell proliferation. Metabolism, kinetics, cell transport, and reaction with specific proteins play a critical role in producing the effects at the cellular level, regardless of cell type, whether urothelium, lung epithelium or epidermis. The cytotoxicity induced by iAs results in non-cancer toxicities, and the regenerative cell proliferation enhances development of epithelial cancers. In other tissues, such as vascular endothelium, different toxicities develop, not cancer. Evidence supporting this MOA comes from in vitro investigations on animal and human cells, from animal models, and from epidemiological studies. This MOA implies a non-linear, threshold dose-response relationship for both non-cancer and cancer end points. The no effect levels in animal models (approximately 1 ppm of water or diet) and in vitro (>0.1 µM trivalent arsenicals) are strikingly consistent. Cancer effects of iAs in humans generally are not observed below exposures of 100-150 ppb in drinking water: below these exposures, human urine concentrations of trivalent metabolites are generally below 0.1 µM, a concentration not associated with bladder cell cytotoxicity in in vitro or animal models. Environmental exposures to iAs in most of the United States do not approach this threshold.
Similar articles
-
Research toward the development of a biologically based dose response assessment for inorganic arsenic carcinogenicity: a progress report.Toxicol Appl Pharmacol. 2007 Aug 1;222(3):388-98. doi: 10.1016/j.taap.2007.03.021. Epub 2007 Mar 30. Toxicol Appl Pharmacol. 2007. PMID: 17499324
-
Quantitative assessment of lung and bladder cancer risk and oral exposure to inorganic arsenic: Meta-regression analyses of epidemiological data.Environ Int. 2017 Sep;106:178-206. doi: 10.1016/j.envint.2017.04.008. Epub 2017 Jun 16. Environ Int. 2017. PMID: 28625818
-
Arsenic-induced bladder cancer in an animal model.Toxicol Appl Pharmacol. 2007 Aug 1;222(3):258-63. doi: 10.1016/j.taap.2006.10.010. Epub 2006 Oct 17. Toxicol Appl Pharmacol. 2007. PMID: 17109909 Review.
-
Use of mode of action data to inform a dose-response assessment for bladder cancer following exposure to inorganic arsenic.Toxicol In Vitro. 2014 Oct;28(7):1196-205. doi: 10.1016/j.tiv.2014.05.011. Epub 2014 Jun 14. Toxicol In Vitro. 2014. PMID: 24937311
-
Arsenic exposure and bladder cancer: quantitative assessment of studies in human populations to detect risks at low doses.Toxicology. 2014 Mar 20;317:17-30. doi: 10.1016/j.tox.2014.01.004. Epub 2014 Jan 21. Toxicology. 2014. PMID: 24462659 Review.
Cited by
-
Characterizing the toxicological responses to inorganic arsenicals and their metabolites in immortalized human bladder epithelial cells.Arch Toxicol. 2024 Jul;98(7):2065-2084. doi: 10.1007/s00204-024-03750-1. Epub 2024 Apr 17. Arch Toxicol. 2024. PMID: 38630284
-
The Correlation between Metal Mixed Exposure and Lung Function in Different Ages of the Population.Metabolites. 2024 Feb 26;14(3):139. doi: 10.3390/metabo14030139. Metabolites. 2024. PMID: 38535299 Free PMC article.
-
Arsenic-induced prostate cancer: an enigma.Med Oncol. 2024 Jan 6;41(2):50. doi: 10.1007/s12032-023-02266-5. Med Oncol. 2024. PMID: 38184511 Review.
-
Biochemical and Behavioural Alterations Induced by Arsenic and Temperature in Hediste diversicolor of Different Growth Stages.Int J Environ Res Public Health. 2022 Nov 22;19(23):15426. doi: 10.3390/ijerph192315426. Int J Environ Res Public Health. 2022. PMID: 36497501 Free PMC article.
-
A Comprehensive Transcriptomic Analysis of Arsenic-Induced Bladder Carcinogenesis.Cells. 2022 Aug 5;11(15):2435. doi: 10.3390/cells11152435. Cells. 2022. PMID: 35954277 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical